Exome sequencing has become a formidable tool for identifying potential de novo variants in causative genes of human diseases, such as neurodegenerative disorders. This article describes a 16-month-old girl with spinal muscular atrophy with lower extremity predominance and a 13-month-old girl with malformations of cortical development. Exome sequencing identified a novel de novo heterozygous missense mutation c.3395G>A (p.Gly1132Glu) and a previously reported de novo heterozygous missense mutation c.10151G>A (p.Arg3384Gln) in the DYNC1H1 gene. Bioinformatics predictions for c.3395G>A and c.10151G>A indicated pathogenicity of the mutations. DYNC1H1 is a pivotal component of cytoplasmic dynein complex, which is a microtubule-related motor involved in retrograde transport. Previous studies indicated that mutant dynein showed decreased run-length of the motor proteins and diminished retrograde transport, which were clearly associated with neuronal death and neurologic diseases. The present findings expand the mutational spectrum of the DYNC1H1 gene, reemphasizing the significance of the DYNC1H1 protein in the functioning of neurons.
HafezparastMKlockeRRuhrbergC. Mutations in Dynein link motor neuron degeneration to defects in retrograde transport. Science. 2003;300:808–812.
2.
ChenXJLevedakouEMMillenKJWollmannRLSolivenBPopkoB. Proprioceptive sensory neuropathy in mice with a mutation in the cytoplasmic dynein heavy chain 1 gene. J Neurosci. 2007;27:14515–14524.
3.
VissersLEde LigtJGilissenC. A de novo paradigm for mental retardation. Nat Genet. 2010;42:1109–1112.
4.
WeedonMNHastingsRCaswellR. Exome sequencing identifies a DYNC1H1 mutation in a large pedigree with dominant axonal Charcot-Marie-Tooth disease. Am J Hum Genet. 2011;89:308–312.
5.
HarmsMBAllredPGardnerRJr. Dominant spinal muscular atrophy with lower extremity predominance linkage to 14q32. Neurology. 2010;75:539–546.
6.
HarmsMBOri-McKenneyKMScotoM. Mutations in the tail domain of DYNC1H1 cause dominant spinal muscular atrophy. Neurology. 2012;78:1714–1720.
7.
WillemsenMHVissersLEWillemsenMA. Mutations in DYNC1H1 cause severe intellectual disability with neuronal migration defects. J Med Genet. 2012;49:179–183.
8.
TsurusakiYSaitohSTomizawaK. A DYNC1H1 mutation causes a dominant spinal muscular atrophy with lower extremity predominance. Neurogenetics. 2012;13:327–332.
9.
PoirierKLebrunNBroixL. Mutations in TUBG1, DYNC1H1, KIF5C and KIF2A cause malformations of cortical development and microcephaly. Nat Genet. 2013; 45:639–647.
10.
FiorilloCMoroFYiJ. Novel dynein DYNC1H1 neck and motor domain mutations link distal spinal muscular atrophy and abnormal cortical development. Hum Mutat. 2014;35:298–302.
11.
ScotoMRossorAMHarmsMB. Novel mutations expand the clinical spectrum of DYNC1H1-associated spinal muscular atrophy. Neurology. 2015;84:668–679.
12.
PunethaJMongesSFranchiMEHoffmanEPCirakSTesi-RochaC. Exome sequencing identifies DYNC1H1 variant associated with vertebral abnormality and spinal muscular atrophy with lower extremity predominance. Pediatr Neurol. 2015;52:239–244.
13.
DingDChenZLiK. Identification of a de novo DYNC1H1 mutation via WES according to published guidelines. Sci Rep. 2016;6:20423.
14.
Paternostro-SlugaTGrim-StiegerMPoschM. Reliability and validity of the Medical Research Council (MRC) scale and a modified scale for testing muscle strength in patients with radial palsy. J Rehabil Med. 2008;40:665–671.
15.
WangJZhangWJiangHWuBL; Primary Ovarian Insufficiency Collaboration. Mutations in HFM1 in recessive primary ovarian insufficiency. N Engl J Med. 2014;370:972–984.
16.
LefebvreSBürglenLReboulletS. Identification and characterization of a spinal muscular atrophy-determining gene. Cell. 1995;80:155–155.
17.
RakicPCavinessVSJr. Cortical development: view from neurological mutants two decades later. Neuron. 1995;14:1101–1104.
18.
ZillesKSchleicherALangemannC. Quantitative analysis of sulci in the human cerebral cortex: development, regional heterogeneity, gender difference, asymmetry, intersubject variability and cortical architecture. Hum Brain Mapp. 1997;5:218–221.
19.
PreussTMQiHKaasJH. Distinctive compartmental organization of human primary visual cortex. Proc Natl Acad Sci U S A. 1999;96:11601–11606.
20.
CavinessVSJrTakahashiTNowakowskiRS. Numbers, time and neocortical neuronogenesis: a general developmental and evolutionary model. Trends Neurosci. 1995;18:379–383.
21.
FrancisFMeyerGFallet-BiancoC. Human disorders of cortical development: from past to present. Eur J Neurosci. 2006;23:877–893.
22.
OstergaardPSimpsonMAMendolaA. Mutations in KIF11 cause autosomal-dominant microcephaly variably associated with congenital lymphedema and chorioretinopathy. Am J Hum Genet. 2012;90:356–362.
23.
BarkovichAJGuerriniRKuznieckyRIJacksonGDDobynsWB. A developmental and genetic classification for malformations of cortical development: update 2012. Brain. 2012;135:1348–1369.
24.
AhmadFJEcheverriCJValleeRBBaasPW. Cytoplasmic dynein and dynactin are required for the transport of microtubules into the axon. J Cell Biol. 1998;140:391–401.
25.
Ori-McKenneyKMXuJGrossSPValleeRB. A cytoplasmic dynein tail mutation impairs motor processivity. Nat Cell Biol. 2010;12:1228–1234.
26.
EschbachJSinnigerJBouitbirJ. Dynein mutations associated with hereditary motor neuropathies impair mitochondrial morphology and function with age. Neurobiol Dis. 2013;58:220–230.
27.
TanakaAClelandMMXuS. Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin. J Cell Biol. 2010;191:1367–1380.
28.
CarterAPGarbarinoJEWilson-KubalekEM. Structure and functional role of dynein’s microtubule-binding domain. Science. 2008;322:1691–1695.
29.
ShuTAyalaRNguyenMDXieZGleesonJGTsaiLH. Ndel1 operates in a common pathway with LIS1 and cytoplasmic dynein to regulate cortical neuronal positioning. Neuron. 2004;44:263–277.
